Plus: Novo Nordisk is set to cut prices of GLP-1’s by as much as half next year. And consumer confidence was up for February. Anthony Bansie hosts.
Sign up for WSJ’s free What’s News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
